Yifan Pharmaceutical: The company's product 2-Fucosyl-lactose has passed the review of the National Health Commission.

On December 5th, Yifan Pharmaceutical announced that its wholly-owned subsidiary, Hangzhou Xinfu Technology Co., Ltd., has received the "Administrative License Review Conclusion Notice" issued by the National Health Commission. The company's administrative license application for 2'-fucosyllactose lactose has been approved after review. 2'-fucosyllactose lactose is a major oligosaccharide found in breast milk, with functions such as regulating intestinal flora, promoting brain development, and enhancing immunity. It can be used in the production of formula milk powder, infant formula food, etc. The approval of this product by the National Health Commission has laid a solid foundation for the company's future industrialization of products. However, the specific production and listing timeline, sales situation, and performance of the product in the future may still be affected by uncertain factors such as changes in market demand, policy adjustments, etc.